Skip to main content

Search

Join Our Contact Registry

RDCRN Alumni badge

Header Social Media

Main navigation

Our Research
Researchers and Clinicians
Patient and Families
Early Stage Investigators
News and Events
About Us
Podcast
- PIDTC Podcast

A Previously-Funded NIH Rare Diseases Clinical Research Network Consortium

PIDTC Newsletters

PIDTC Updates

Newsletter of the Primary Immune Deficiency Treatment Consortium

| Sep 2026

Issue 24 | Summer

Learn More

Newsletter Image

Join Our Email List

Aug 2025 | Issue 23 | Summer

Jan 2025 | Issue 22 | Winter

Nov 2024 | Issue 21 | Fall

Jul 2024 | Issue 20 | Summer

Jun 2024 | Issue 19 | Spring

Jan 2023 | Issue 17 | Winter

Aug 2022 | Issue 16 | Summer

Apr 2022 | Issue 15 | Spring

Jan 2022 | Issue 14 | Winter/Spring

Jul 2021 | Issue 13 | Summer

Load More

Footer menu

Web Policies
Genetic and Rare Diseases Information Center
Members Login
Contact Us

The Primary Immune Deficiency Treatment Consortium (PIDTC) is a previously funded research group of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). PIDTC received funding under grant number U54AI082973 as a collaboration between NCATS and the National Institute of Allergy and Infectious Diseases (NIAID). This website is hosted by the network’s Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and the National Institute of Neurological Disorders and Stroke NINDS) under grant number TR002818. The content of this website is solely the responsibility of the PIDTC administrative coordinating center at University of California, San Francisco and does not necessarily represent the official views of the NIH.

social media